ANOVA |
Analysis of variance |
ATP |
Adenosine triphosphate |
BC |
Bladder cancer |
cf |
Cell-free |
EMT |
Epithelial-to-mesenchymal transition |
EV |
Extracellular vesicle |
FDR |
False discovery rate |
HC |
Healthy control |
HCD |
Higher-energy collisional dissociation |
LC-MS/MS |
Liquid chromatography followed by tandem mass spectrometry |
MCL |
Markov clustering |
MIBC |
Muscle-invasive bladder cancer |
MTBE |
Methyl-tert-butyl-ether |
MVBs |
multivesicular bodies |
NMIBC |
Non-muscle-invasive bladder cancer |
NTA |
Nanoparticle tracking analysis |
PD |
Proteome discoverer |
ppm |
Parts per million |
QC |
Quality control |
SEC |
Size-exclusion chromatography |
sEV |
Small extracellular vesicles |
STRING |
Search tool for the retrieval of interacting genes |
TEM |
Transmission electron microscopy |
UF |
Ultrafiltration |
UPS |
Ubiquitin proteasome system |